|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Lipid Research, Vol. 45, 99-105, January 2004
Copyright © 2004 by American Society for Biochemistry and Molecular Biology



* Department of Biochemistry and Molecular Biology, University of the Basque Country, P.O. Box 644, 48080 Bilbao, Spain
Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
1 To whom correspondence should be addressed. e-mail: gbpgomua{at}lg.ehu.es
It was reported previously that ceramide-1-phosphate (Cer-1-P) is mitogenic for fibroblasts (Gómez-Muñoz, A., P. A. Duffy, A. Martin, L. O'Brien, H-S. Byun, R. Bittman, and D. N. Brindley. 1995. Mol. Pharmacol. 47: 883889; Gómez-Muñoz, A., L. M. Frago, L. Alvarez, and I. Varela-Nieto. 1997. Biochem. J. 325: 435440). We now show that Cer-1-P prevents cell death in bone-marrow-derived macrophages (BMDMs) after withdrawal of macrophage colony-stimulating factor (M-CSF). Removal of M-CSF is known to induce apoptosis in these cells. Cer-1-P blocked activation of the caspase-9/caspase-3 pathway and prevented DNA fragmentation, indicating that the enhancement of cell survival was due to inhibition of apoptosis. M-CSF deprivation resulted in activation of acid sphingomyelinase (A-SMase), increased ceramide levels, and a decrease in intracellular Cer-1-P. Exogenously added Cer-1-P inhibited A-SMase in intact BMDMs at concentrations that also prevented apoptosis. Cer-1-P also inhibited A-SMase in cell homogenates, suggesting a possible direct physical interaction of Cer-1-P with the enzyme.
In conclusion, these data demonstrate that Cer-1-P blocks apoptosis in BMDMs through inhibition of A-SMase, thereby reducing ceramide generation. This adds a new dimension to the understanding of the metabolic interrelationship of ceramides and Cer-1-P, and shows how altering the balance of intracellular levels of these mediators can affect cell survival.
Abbreviations: A-SMase, acid sphingomyelinase; BMDMs, bone marrow-derived macrophages; C2-, acetyl; C8-, octanoyl; Cer-1-P, ceramide-1-phosphate; ERK, extracellular-regulated kinase; MAPK, mitogen-activated protein kinase; M-CSF, macrophage colony-stimulating factor; MTS, [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulphophenyl)-2H-tetrazolium, inner salt]; Sph-1-P, sphingosine-1-phosphate
Supplementary key words sphingosine-1-phosphate caspases cell survival
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. Graf, M. Klumpp, M. Habig, P. Rovina, A. Billich, T. Baumruker, B. Oberhauser, and F. Bornancin Targeting Ceramide Metabolism with a Potent and Specific Ceramide Kinase Inhibitor Mol. Pharmacol., October 1, 2008; 74(4): 925 - 932. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E. Kooijman, J. Sot, L.-R. Montes, A. Alonso, A. Gericke, B. de Kruijff, S. Kumar, and F. M. Goni Membrane Organization and Ionization Behavior of the Minor but Crucial Lipid Ceramide-1-Phosphate Biophys. J., June 1, 2008; 94(11): 4320 - 4330. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Boath, C. Graf, E. Lidome, T. Ullrich, P. Nussbaumer, and F. Bornancin Regulation and Traffic of Ceramide 1-Phosphate Produced by Ceramide Kinase: COMPARATIVE ANALYSIS TO GLUCOSYLCERAMIDE AND SPHINGOMYELIN J. Biol. Chem., March 28, 2008; 283(13): 8517 - 8526. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Hinkovska-Galcheva, A. Clark, S. VanWay, J.-B. Huang, M. Hiraoka, A. Abe, M. Borofsky, R. G. Kunkel, T. Shanley, J. A. Shayman, et al. Ceramide kinase promotes Ca2+ signaling near IgG-opsonized targets and enhances phagolysosomal fusion in COS-1 cells J. Lipid Res., March 1, 2008; 49(3): 531 - 542. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Graf, B. Zemann, P. Rovina, N. Urtz, A. Schanzer, R. Reuschel, D. Mechtcheriakova, M. Muller, E. Fischer, C. Reichel, et al. Neutropenia with Impaired Immune Response to Streptococcus pneumoniae in Ceramide Kinase-Deficient Mice J. Immunol., March 1, 2008; 180(5): 3457 - 3466. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. F. Lamour, R. V. Stahelin, D. S. Wijesinghe, M. Maceyka, E. Wang, J. C. Allegood, A. H. Merrill Jr., W. Cho, and C. E. Chalfant Ceramide kinase uses ceramide provided by ceramide transport protein: localization to organelles of eicosanoid synthesis J. Lipid Res., June 1, 2007; 48(6): 1293 - 1304. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Tauzin, C. Graf, M. Sun, P. Rovina, N. Bouveyron, M. Jaritz, A. Winiski, N. Hartmann, F. Staedtler, A. Billich, et al. Effects of ceramide-1-phosphate on cultured cells: dependence on dodecane in the vehicle J. Lipid Res., January 1, 2007; 48(1): 66 - 76. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Morris, L. M. Schang, and D. N. Brindley Lipid Phosphate Phosphatase-2 Activity Regulates S-phase Entry of the Cell Cycle in Rat2 Fibroblasts J. Biol. Chem., April 7, 2006; 281(14): 9297 - 9306. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Van Overloop, S. Gijsbers,, and P. P. Van Veldhoven Further characterization of mammalian ceramide kinase: substrate delivery and (stereo)specificity, tissue distribution, and subcellular localization studies J. Lipid Res., February 1, 2006; 47(2): 268 - 283. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Wijesinghe, A. Massiello, P. Subramanian, Z. Szulc, A. Bielawska, and C. E. Chalfant Substrate specificity of human ceramide kinase J. Lipid Res., December 1, 2005; 46(12): 2706 - 2716. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |